Literature DB >> 30711213

(Outcome) Measure for (Intervention) Measures: A Guide to Choosing the Appropriate Noninvasive Clinical Outcome Measure for Intervention Studies in Celiac Disease.

Prashant Singh1, Jocelyn A Silvester2, Daniel Leffler3.   

Abstract

There is an unmet need for diagnostic and treatment interventions for celiac disease. Both clinical trials and real-world studies require careful selection of clinical outcome measures. Often, neither serology nor histology is an appropriate primary outcome. This article reviews various measures of intestinal function and nutrition, patient-reported outcome measures for symptoms and for health-related quality of life, and measures of sickness burden as they apply to intervention studies for celiac disease. A series of case studies is presented to illustrate key considerations in selecting outcome measures for dietary interventions, pharmacologic interventions, and real-world studies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Celiac disease; Intervention studies; Outcome measures; Patient-reported outcomes; Study design

Mesh:

Substances:

Year:  2018        PMID: 30711213      PMCID: PMC6368393          DOI: 10.1016/j.gtc.2018.09.006

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  54 in total

Review 1.  SF-36 health survey update.

Authors:  J E Ware
Journal:  Spine (Phila Pa 1976)       Date:  2000-12-15       Impact factor: 3.468

2.  Mortality in patients with coeliac disease and their relatives: a cohort study.

Authors:  G Corrao; G R Corazza; V Bagnardi; G Brusco; C Ciacci; M Cottone; C Sategna Guidetti; P Usai; P Cesari; M A Pelli; S Loperfido; U Volta; A Calabró; M Certo
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

3.  A trial of oats in children with newly diagnosed celiac disease.

Authors:  E J Hoffenberg; J Haas; A Drescher; R Barnhurst; I Osberg; F Bao; G Eisenbarth
Journal:  J Pediatr       Date:  2000-09       Impact factor: 4.406

4.  Quality of life in screen-detected and typical coeliac disease and the effect of excluding dietary gluten.

Authors:  Simon D Johnston; Colin Rodgers; R Gpeter Watson
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-11       Impact factor: 2.566

5.  Living with coeliac disease: controlled study of the burden of illness.

Authors:  C Hallert; C Grännö; S Hultén; G Midhagen; M Ström; H Svensson; T Valdimarsson
Journal:  Scand J Gastroenterol       Date:  2002-01       Impact factor: 2.423

6.  Understanding DALYs (disability-adjusted life years).

Authors:  C J Murray; A K Acharya
Journal:  J Health Econ       Date:  1997-12       Impact factor: 3.883

7.  Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.

Authors:  Marco Daperno; Geert D'Haens; Gert Van Assche; Filip Baert; Philippe Bulois; Vincent Maunoury; Raffaello Sostegni; Rodolfo Rocca; Angelo Pera; Annemie Gevers; Jean-Yves Mary; Jean-Frédéric Colombel; Paul Rutgeerts
Journal:  Gastrointest Endosc       Date:  2004-10       Impact factor: 9.427

8.  Psychological support counselling improves gluten-free diet compliance in coeliac patients with affective disorders.

Authors:  G Addolorato; G De Lorenzi; L Abenavoli; L Leggio; E Capristo; G Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2004-10-01       Impact factor: 8.171

9.  Structural basis for gluten intolerance in celiac sprue.

Authors:  Lu Shan; Øyvind Molberg; Isabelle Parrot; Felix Hausch; Ferda Filiz; Gary M Gray; Ludvig M Sollid; Chaitan Khosla
Journal:  Science       Date:  2002-09-27       Impact factor: 47.728

10.  Gluten-free diet and quality of life in patients with screen-detected celiac disease.

Authors:  Kirsi Mustalahti; Susanna Lohiniemi; Pekka Collin; Nanna Vuolteenaho; Pekka Laippala; Markku Mäki
Journal:  Eff Clin Pract       Date:  2002 May-Jun
View more
  1 in total

1.  Nutrient intake differs among persons with celiac disease and gluten-related disorders in the United States.

Authors:  Aynur Unalp-Arida; Rui Liu; Constance E Ruhl
Journal:  Sci Rep       Date:  2022-04-02       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.